SPY396.92+7.29 1.87%
DIA318.84+6.42 2.05%
IXIC11,535.28+180.66 1.59%

-- Antibe Therapeutics Brief: Details Strategic Sale of Citagenix Subsidiary; $6.5 million All-cash Transaction, Including Milestone Payments; Enables Exclusive Focus On Drug Pipeline

MT Newswires · 05/02/2022 03:23

Please log in to view news